Table 2.

Comparison of responses by gastroenterologists and hepatologists to those survey questions with guideline-based answers.

Selected guideline related questions	Guideline based answer	GI-hepatologists adherent to guideline	Hepatologists adherent to guideline	p value
Are elevated liver enzymes required for you to consider liver biopsy in patients with fatty liver identified on imaging?	No	27/67 (40%)	41/90 (46%)	0.52
If you use vitamin E, do you require biopsy confirmed NASH before starting therapy?	Yes	23/55 (42%)	42/90 (47%)	0.61
If you use pioglitazone, do you require biopsy confirmed NASH before starting therapy?	Yes	22/37 (59%)	36/49 (73%)	0.25
Are there are subgroups of patients to whom you do not prescribe vitamin E?	Yes – diabetics and cirrhotics	33/56 (59%)	40/77 (52%)	0.48

GI, gastrointestinal; NASH, nonalcoholic steatohepatitis.